Cargando…

Cryptophane–xenon complexes for (129)Xe MRI applications

The use of magnetic resonance imaging (MRI) and spectroscopy (MRS) in the clinical setting enables the acquisition of valuable anatomical information in a rapid, non-invasive fashion. However, MRI applications for identifying disease-related biomarkers are limited due to low sensitivity at clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Zemerov, Serge D., Dmochowski, Ivan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570548/
https://www.ncbi.nlm.nih.gov/pubmed/34745572
http://dx.doi.org/10.1039/d0ra10765d
_version_ 1784594862347124736
author Zemerov, Serge D.
Dmochowski, Ivan J.
author_facet Zemerov, Serge D.
Dmochowski, Ivan J.
author_sort Zemerov, Serge D.
collection PubMed
description The use of magnetic resonance imaging (MRI) and spectroscopy (MRS) in the clinical setting enables the acquisition of valuable anatomical information in a rapid, non-invasive fashion. However, MRI applications for identifying disease-related biomarkers are limited due to low sensitivity at clinical magnetic field strengths. The development of hyperpolarized (hp) (129)Xe MRI/MRS techniques as complements to traditional (1)H-based imaging has been a burgeoning area of research over the past two decades. Pioneering experiments have shown that hp (129)Xe can be encapsulated within host molecules to generate ultrasensitive biosensors. In particular, xenon has high affinity for cryptophanes, which are small organic cages that can be functionalized with affinity tags, fluorophores, solubilizing groups, and other moieties to identify biomedically relevant analytes. Cryptophane sensors designed for proteins, metal ions, nucleic acids, pH, and temperature have achieved nanomolar-to-femtomolar limits of detection via a combination of (129)Xe hyperpolarization and chemical exchange saturation transfer (CEST) techniques. This review aims to summarize the development of cryptophane biosensors for (129)Xe MRI applications, while highlighting innovative biosensor designs and the consequent enhancements in detection sensitivity, which will be invaluable in expanding the scope of (129)Xe MRI.
format Online
Article
Text
id pubmed-8570548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-85705482022-02-17 Cryptophane–xenon complexes for (129)Xe MRI applications Zemerov, Serge D. Dmochowski, Ivan J. RSC Adv Chemistry The use of magnetic resonance imaging (MRI) and spectroscopy (MRS) in the clinical setting enables the acquisition of valuable anatomical information in a rapid, non-invasive fashion. However, MRI applications for identifying disease-related biomarkers are limited due to low sensitivity at clinical magnetic field strengths. The development of hyperpolarized (hp) (129)Xe MRI/MRS techniques as complements to traditional (1)H-based imaging has been a burgeoning area of research over the past two decades. Pioneering experiments have shown that hp (129)Xe can be encapsulated within host molecules to generate ultrasensitive biosensors. In particular, xenon has high affinity for cryptophanes, which are small organic cages that can be functionalized with affinity tags, fluorophores, solubilizing groups, and other moieties to identify biomedically relevant analytes. Cryptophane sensors designed for proteins, metal ions, nucleic acids, pH, and temperature have achieved nanomolar-to-femtomolar limits of detection via a combination of (129)Xe hyperpolarization and chemical exchange saturation transfer (CEST) techniques. This review aims to summarize the development of cryptophane biosensors for (129)Xe MRI applications, while highlighting innovative biosensor designs and the consequent enhancements in detection sensitivity, which will be invaluable in expanding the scope of (129)Xe MRI. The Royal Society of Chemistry 2021-02-17 /pmc/articles/PMC8570548/ /pubmed/34745572 http://dx.doi.org/10.1039/d0ra10765d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Zemerov, Serge D.
Dmochowski, Ivan J.
Cryptophane–xenon complexes for (129)Xe MRI applications
title Cryptophane–xenon complexes for (129)Xe MRI applications
title_full Cryptophane–xenon complexes for (129)Xe MRI applications
title_fullStr Cryptophane–xenon complexes for (129)Xe MRI applications
title_full_unstemmed Cryptophane–xenon complexes for (129)Xe MRI applications
title_short Cryptophane–xenon complexes for (129)Xe MRI applications
title_sort cryptophane–xenon complexes for (129)xe mri applications
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570548/
https://www.ncbi.nlm.nih.gov/pubmed/34745572
http://dx.doi.org/10.1039/d0ra10765d
work_keys_str_mv AT zemerovserged cryptophanexenoncomplexesfor129xemriapplications
AT dmochowskiivanj cryptophanexenoncomplexesfor129xemriapplications